LAB PHARMA AS

Signals

3 flags

• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−2,2 mill kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−2,9 mill kr).
• ◎ Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.

LAB PHARMA AS is registered as a limited company in Oslo, Oslo with organisation number 997105028. The business is classified under retail sale of other food (NACE 47.270). The company was incorporated in 2011. Registered share capital is NOK 500,000, divided into 500 shares. The company's stated purpose is: “Utvikling og salg av helsekostprodukter og naturlegemidler, samt alt som hører naturlig til dette, herunder å delta i andre selskaper.”. The most recent filed accounts, for the 2024 financial year, show NOK 26.2m in revenue and NOK −2.9m in operating profit.

Key figures · 2024

Revenue

NOK 26.2m

Operating profit

NOK −2.9m

Equity

NOK −2.2m

Financial health · 2024

Liquidity

0.65

Weak

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-39.4%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns LAB PHARMA AS?

TER REK AS

100.0%

LAB PHARMA AS

NOK 26.2m rev. · NOK −2.9m profit

LAB PHARMA AS has 1 registered shareholder:

• TER REK AS 100.0%

All shareholders and roles →

Frequently asked questions about LAB PHARMA AS

Who owns LAB PHARMA AS?

TER REK AS is the largest registered owner, with 100.0%.

What is the revenue of LAB PHARMA AS?

LAB PHARMA AS had revenue of NOK 26.2m in 2024.

Who is the general manager of LAB PHARMA AS?

Haakon Ringerike Hoftun is registered as general manager of LAB PHARMA AS.

Where is LAB PHARMA AS based?

LAB PHARMA AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.